Pulmicort and Hepatic necrosis - a phase IV clinical study of FDA data

Summary:

Hepatic necrosis is reported as a side effect among people who take Pulmicort (budesonide), especially for people who are female, 60+ old, have been taking the drug for 1 - 6 months also take Flovent, and have Constipation.

The phase IV clinical study analyzes which people have Hepatic necrosis when taking Pulmicort. It is created by eHealthMe based on reports of 34,552 people who have side effects when taking Pulmicort from the FDA, and is updated regularly.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

What is Hepatic necrosis?

Hepatic necrosis (large portions of liver die off due to severe liver disease) is found to be associated with 595 drugs and 743 conditions by eHealthMe. Check the latest studies of Hepatic necrosis.

On Jul, 09, 2026

34,552 people reported to have side effects when taking Pulmicort.
Among them, 12 people (0.03%) have Hepatic necrosis.

Among these 12 people:

How long have people been on Pulmicort when they have Hepatic necrosis? *

What is the gender of people who have Hepatic necrosis when taking Pulmicort? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Hepatic necrosis when taking Pulmicort? *

What are other drugs people take besides Pulmicort? *

What are other side effects people have besides Hepatic necrosis? *

Weakness: 3 people, 25.00%
Nausea And Vomiting: 3 people, 25.00%
Hepatotoxicity (chemical-driven liver damage): 3 people, 25.00%
Hepatitis (inflammation of the liver): 3 people, 25.00%
Nausea (feeling of having an urge to vomit): 3 people, 25.00%
Abdominal Pain Upper: 3 people, 25.00%
Acute Hepatic Failure: 3 people, 25.00%
Acute Right Ventricular Failure (acute heart attack): 2 people, 16.67%
Headache (pain in head): 2 people, 16.67%
Nasal Discomfort: 2 people, 16.67%

What are the existing conditions these people have? *

Spinal Muscular Atrophy (wasting of spinal muscles): 3 people, 25.00%
Lung Disorder (lung disease): 3 people, 25.00%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 25.00%
Dyspnea (difficult or laboured breathing): 3 people, 25.00%
Cough: 3 people, 25.00%
Constipation: 3 people, 25.00%
Sinusitis (inflammation of sinus): 2 people, 16.67%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 16.67%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 8.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmicort and have Hepatic necrosis?

- Check whether Hepatic necrosis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmicort:

Pulmicort (34,980 reports)

Browse all side effects of Pulmicort:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hepatic necrosis:

Hepatic necrosis (595 drugs)

Browse all the conditions that are associated with Hepatic necrosis:

Hepatic necrosis (743 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on budesonide (the active ingredients of Pulmicort) and Pulmicort (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.